Article thumbnail

ENPP1 Affects Insulin Action and Secretion: Evidences from In Vitro Studies

By Rosa Di Paola, Nunzia Caporarello, Antonella Marucci, Claudia Dimatteo, Claudia Iadicicco, Silvia Del Guerra, Sabrina Prudente, Dora Sudano, Claudia Miele, Cristina Parrino, Salvatore Piro, Francesco Beguinot, Piero Marchetti, Vincenzo Trischitta and Lucia Frittitta


The aim of this study was to deeper investigate the mechanisms through which ENPP1, a negative modulator of insulin receptor (IR) activation, plays a role on insulin signaling, insulin secretion and eventually glucose metabolism. ENPP1 cDNA (carrying either K121 or Q121 variant) was transfected in HepG2 liver-, L6 skeletal muscle- and INS1E beta-cells. Insulin-induced IR-autophosphorylation (HepG2, L6, INS1E), Akt-Ser473, ERK1/2-Thr202/Tyr204 and GSK3-beta Ser9 phosphorylation (HepG2, L6), PEPCK mRNA levels (HepG2) and 2-deoxy-D-glucose uptake (L6) was studied. GLUT 4 mRNA (L6), insulin secretion and caspase-3 activation (INS1E) were also investigated. Insulin-induced IR-autophosphorylation was decreased in HepG2-K, L6-K, INS1E-K (20%, 52% and 11% reduction vs. untransfected cells) and twice as much in HepG2-Q, L6-Q, INS1E-Q (44%, 92% and 30%). Similar data were obtained with Akt-Ser473, ERK1/2-Thr202/Tyr204 and GSK3-beta Ser9 in HepG2 and L6. Insulin-induced reduction of PEPCK mRNA was progressively lower in untransfected, HepG2-K and HepG2-Q cells (65%, 54%, 23%). Insulin-induced glucose uptake in untransfected L6 (60% increase over basal), was totally abolished in L6-K and L6-Q cells. GLUT 4 mRNA was slightly reduced in L6-K and twice as much in L6-Q (13% and 25% reduction vs. untransfected cells). Glucose-induced insulin secretion was 60% reduced in INS1E-K and almost abolished in INS1E-Q. Serum deficiency activated caspase-3 by two, three and four folds in untransfected INS1E, INS1E-K and INS1E-Q. Glyburide-induced insulin secretion was reduced by 50% in isolated human islets from homozygous QQ donors as compared to those from KK and KQ individuals. Our data clearly indicate that ENPP1, especially when the Q121 variant is operating, affects insulin signaling and glucose metabolism in skeletal muscle- and liver-cells and both function and survival of insulin secreting beta-cells, thus representing a strong pathogenic factor predisposing to insulin resistance, defective insulin secretion and glucose metabolism abnormalities

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1996). A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.
  2. (1999). A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance.
  3. (2004). Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells.
  4. (1998). Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling.
  5. (2009). ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells.
  6. (2009). Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity.
  7. (2005). Functional and molecular defects of pancreatic islets in human type 2 diabetes.
  8. (2003). Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance.
  9. (2004). Glucosamine-induced alterations of mitochondrial function in pancreatic Bcells: possible role of protein glycosilation.
  10. (2010). Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells.
  11. (2003). Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism.
  12. (1999). Increased activity of membrane glycoprotein PC-1 in the fibroblasts from non-insulindependent diabetes mellitus patients with insulin resistance.
  13. (1997). Increased adipose tissue PC-1 protein content, but not tumour necrosis factoralpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity.
  14. (2005). Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance.
  15. (2007). Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance.
  16. (1993). Insulin resistance and insulin secretory dysfunction as precursors of non-insulindependent diabetes mellitus. Prospective studies of Pima Indians.
  17. (1995). Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1.
  18. (2002). Insulin secretory function is impaired in isolated human islets carrying the Gly(972)R Arg IRS-1 polymorphism.
  19. (2009). Insulin signaling regulating genes: effect on T2DM and cardiovascular risk.
  20. (2003). Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes.
  21. (1988). Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.
  22. (1995). Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus.
  23. (2000). Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alphasubunit.
  24. (2008). missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study.
  25. (1996). Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity.
  26. (2011). Prep1 controls insulin glucoregulatory function in liver by transcriptional targeting of SHP1 tyrosine phosphatase.
  27. (1999). Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.
  28. (2004). Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice.
  29. (2008). Role of the ENPP1 K121Q polymorphism in glucose homeostasis.
  30. (2000). Roles of insulin receptor substrate-1, phosphatidylinositol 3-kinase, and release of intracellular Ca2+ stores in insulin-stimulated insulin secretion in beta -cells.
  31. (1990). Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.
  32. (2005). Sulfonylurea induced beta-cell apoptosis in cultured human islets.
  33. (2009). Suppression of PC-1/ ENPP-1 expression improves insulin sensitivity in vitro and in vivo.
  34. (2004). Synergistic effect on insulin secretion from INS-1 cells of a sulfonylurea and a phosphodiesterase 3 inhibitor.
  35. (2007). The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients.
  36. (2011). The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients.
  37. (2005). The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy.
  38. (2001). The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans.
  39. (1999). The Gly972RArg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells.
  40. (2000). The GlyRArg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells.
  41. (2010). The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells.
  42. (2001). The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121).
  43. (2009). The role of HSP70 on ENPP1 expression and insulin-receptor activation.
  44. (2008). The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.
  45. (2009). The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes.
  46. (1999). Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.
  47. (2007). Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes.
  48. (2010). TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion.
  49. (2008). TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells.
  50. (2010). Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis.
  51. (2010). Type 2 diabetes susceptibility gene expression in normal or diabetic sorted human alpha and beta cells: correlations with age or BMI of islet donors.